Rafael Amado Insider Profile
4 Followers
Rafael Amado, President, R&D at Adaptimmune Therapeutics, holds 57.02K shares in Zai Lab (Ticker: ZLAB), holds 0.00 shares in Poseida Therapeutics (Ticker: PSTX), holds 541.95K shares in Allogene Therapeutics (Ticker: ALLO). Most recently, Rafael Amado Sold ― shares of Zai Lab on Apr 08, 2026 for an estimated value of $55.99K.
Rafael Amado has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rafael Amado holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Rafael Amado
Rafael Amado's Trading History
Adaptimmune Therapeutics
Aug 07, 2019
President, R&D
Uninformative Sell
22.75K
$344.74
Allogene Therapeutics
Oct 11, 2022
EVP of R&D
Uninformative Buy
―
$1.66M
Zai Lab
Apr 08, 2026
President, Head of Global Oncology Research and Development
Informative Sell
55.99K
$1.22M
Poseida Therapeutics
Jan 08, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Rafael Amado's performance on stock
You May Also Like
Rafael Amado insider profile FAQ
What is the percentage of profitable transactions made by Rafael Amado?
The percentage of profitable transactions made by Rafael Amado is ―.
What is the average return per transaction made by Rafael Amado?
The average return per transaction made by Rafael Amado is ―.
What stocks does Rafael Amado hold?
Rafael Amado holds: ADAPY, ALLO, ZLAB, PSTX stocks.
What was Rafael Amado’s latest transaction?
Rafael Amado latest transaction was an Informative Sell of $55.99K.
What was Rafael Amado's most profitable transaction?
Rafael Amado’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Rafael Amado's role in Adaptimmune Therapeutics?
Rafael Amado's role in Adaptimmune Therapeutics is President, R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.